Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Total Debt (2020)

Historic Total Debt for Caribou Biosciences (CRBU) over the last 1 years, with Q4 2020 value amounting to $924000.0.

  • Caribou Biosciences' Total Debt changed N/A to $924000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $924000.0, marking a year-over-year change of. This contributed to the annual value of $924000.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, Caribou Biosciences' Total Debt is $924000.0.
  • In the past 5 years, Caribou Biosciences' Total Debt ranged from a high of $924000.0 in Q4 2020 and a low of $924000.0 during Q4 2020